logo
  

Bayer Gains Access To Mammoth Biosciences' Gene-editing Technology - Quick Facts

Bayer AG (BAYZF.PK,BAYRY.PK,BYR.L) and Mammoth Biosciences, Inc. entered a strategic collaboration and option agreement for the use of Mammoth's CRISPR systems to develop in vivo gene-editing therapies. Mammoth Biosciences will receive an upfront payment of $40 million and is eligible to receive target option exercise fees as well as potential future payments in the magnitude of more than $1 billion upon successful achievement of certain milestones across five preselected in vivo indications with a first focus on liver-targeted diseases.

"Bringing together Mammoth's novel CRISPR systems with our existing gene augmentation and our induced pluripotent stem cell platforms will allow us to unleash the full potential of our cell and gene therapy strategy," said Stefan Oelrich, Member of the Board of Management, Bayer AG

Also, Bayer will pay research funding and tiered royalties up to low double-digit percentage of net sales.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Asweets Global Inc. is recalling about 2,000 units of Wonder & Wise Activity Tables for potential risk of choking hazard to young children, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the screws of the tables can become loose and/or detach from the xylophone component of the activity tables to pose a choking hazard to young children. Chinese e-commerce giant Alibaba Group Holdings Ltd. (BABA) reported Thursday a net loss for the fourth quarter that sharply widened from last year, despite 9 percent growth in revenues, hurt by a decreases in the market prices of our equity investments in publicly-traded companies. Omni-channel fashion retailer Macy's, Inc. (M) reported Thursday a first-quarter net income of $286 million or $0.98 per share, sharply higher than $103 million or $0.32 per share in the prior-year quarter. Excluding items, adjusted net income for the quarter was $315 million or $1.08 per share, compared...
Follow RTT